Condition
Healthy Volunteers Type 2 Diabetes
Locations
Canada
Start date
15/10/2024
Identifiers
Trial ID
NN9501-5006,
NCT number NCT06642584,
Eudract number Not Available
NCT number NCT06642584,
Eudract number Not Available
Summary
This study is conducted to compare four different tablets containing the investigational medicine semaglutide at the same dose. It is done to test how semaglutide in each of the tablet versions is taken up in the body. Which treatments participants will receive is decided by chance. The study will last for about 28 weeks. The study will enroll healthy male participants.
Trial Overview:
Treatment
DRUG: Semaglutide B
DRUG: Semaglutide J
DRUG: Semaglutide L
DRUG: Semaglutide M
DRUG: Semaglutide N
Study type
INTERVENTIONAL
Trial duration
Oct 15 2024 - May 25 2025
Participants
90
Phase
I
Are you eligible?
Gender
MALE
Age
18 to 64 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.